Intellia Therapeutics (NASDAQ:NTLA) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($1.34) earnings per share for the quarter, beating the consensus estimate of ($1.37) by $0.03, Briefing.com reports. The firm had revenue of $9.10 million during the quarter, compared to the consensus estimate of $8.28 million. During the same […]

Leave a Reply

Your email address will not be published.

Previous post UBS Group Issues Pessimistic Forecast for Dine Brands Global (NYSE:DIN) Stock Price
Next post Qiagen (NYSE:QGEN) Issues FY24 Earnings Guidance